Table: Chugai Pharm -9-MTH group results (IFRS)

Chugai Pharmaceutical

24/10/2025 09:00

Oct 24 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Sep 30, 2025        Sep 30, 2024     Dec 31, 2025 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              911.64              868.54                     
                   (+5.0 pct)          (+3.7 pct)                   
  Operating          429.83              418.60                     
                   (+2.7 pct)          (+31.8 pct)                  
  Pretax
  Net                305.60              295.76                     
                   (+3.3 pct)          (+26.2 pct)                  
  EPS Basic        185.70 yen          179.75 yen                   
  EPS Diluted      185.70 yen          179.72 yen                   
  Ann Div                               98.00 yen       250.00 yen  
  -Q2 Div          125.00 yen           41.00 yen                   
  -Q4 Div                               57.00 yen       125.00 yen  
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T